NEWS
Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments
Inspira Technologies OXY B.H.N. (Nasdaq: IINN, IINNW) announced significant milestones, including FDA clearance for its INSPIRA™ ART100 system. The company will present its business targets and distribution agreements in a conference call on June 20, 2024, at 9:00 am Eastern Time. Company President and co-founder Joe Hayon will lead the discussion, providing insights into Inspira's future steps.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment